Clinical Trials Logo

Clinical Trial Summary

All participants will have a physical activity monitor placed onto the right thigh in the midline which will start collecting data at midnight on the first postoperative day. This will continue until discharge or day 7, whichever is earlier. This is a non-invasive measure of activity and can discriminate between whether a patient is lying, sitting, standing or walking. There is no control group.


Clinical Trial Description

Recruited patients from the colorectal clinic at the Royal Derby Hospital will be invited to be included in the study, and can either attend the University of Nottingham, Centre Of Metabolism, Ageing & Physiology (COMAP) research group unit at the Royal Derby Hospital Centre or discuss the trial in detail over the phone after which a consent form will be sent to them (either by post or email). If they agree to inclusion in the study the consent form will be brought with them to be completed on the day of surgery. On the morning of surgery they will have their consent recorded and the activPAL™ accelerometer applied to the anterior thigh. The activPAL™ is a non-invasive physical monitor that records periods spent, lying, walking and engaging in more strenuous activity. This will remain in situ for 7 days, or until discharge, whichever comes first. The investigators will ask participants to complete a short diary to note down any times the monitor is removed and the time of sleep and waking. After removal - the data is uploaded (it does not include any person-identifiable data) for analysis using software on a local computer in the COMAP unit. After discharge, they will have 2 x telephone calls and/or emails at day 10 and at day 28 to follow up from the research team to monitor progress for the next 30 days. If they develop any complications including readmission data within that time period, this will be collected from the participants' notes along with demographic data and postoperative pathology and recorded. Complications will be graded as per the Clavien-Dindo Classification system. On postoperative day 3, day 5 and day 7 (if still an inpatient) they will also be asked to complete the Hospital Anxiety and Depression Scale (HADS) paper questionnaire. Just prior to discharge, they will complete the discharge questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05934643
Study type Observational
Source University of Nottingham
Contact Melanie Paul, MBChB, MSc
Phone (+44) 01332724640
Email melanie.paul@nhs.net
Status Not yet recruiting
Phase
Start date September 1, 2023
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Withdrawn NCT04831827 - Promoting Equity for Cancer Screening and Follow-up N/A
Recruiting NCT06272461 - Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery N/A
Completed NCT05933408 - TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?
Not yet recruiting NCT05317351 - A Prospective Randomized Study Comparing the Adenoma Detection Yield of SC, AI and Combined AI and G-EYE® N/A
Recruiting NCT05287165 - Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms Early Phase 1
Recruiting NCT05051046 - Colorectal Cancer Screnning Colonoscopy Under Hypnosis N/A
Completed NCT06316401 - Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia